logo

Tag

Pricing
Pharma Brexit Brief Quick Facts

Pharma Brexit Brief

What is Pharma Brexit Brief? It is a living source of updated brief key points to watch for the pharmaceutical industry on Brexit, “deal” or “no-deal” resolution. Pharma Brexit Brief is a single source of information to refer to. Brexit´s Key Impact Aspects on Pharmaceutical Industry: Labor: UK is the third largest country in the EU (after Germany and Switzerland) to utilize pharmaceutical R&D funds of pharmaceut
Read More

Understand Changes in Drug Pricing in Bulgaria

On April 1st, 2019, few regulation on drug pricing and inclusion in the positive drug list were updated and in force. Here is a brief summary of the rules that impact directly drug prices in Bulgaria
Read More

Tendering & Contracting Practice in Europe

ПРАКТИКИ ЗА ТЪРГОВЕ И КОНТРАКТИ ЗА ФАРМАЦЕВТИЧНИ ПРОДУКТИ В ЕВРОПА
Read More
Parallel Trade of Pharmaceuticals

Restrictions on parallel trade in pharmaceuticals

The article is only available in Bulgarian, read the full article via ResearchGate web site.
Read More
EPR Overview Bulgaria

Brief EPR overview & prognosis, the Bulgaria’s perspective

The debate over fare medicinal products pricing is one of the most contentious issues that emerges again within the EU countries. External price referencing (EPR) is used by many EU member states (and others) for the last years as a measure and tool to control marketed medicinal products’ prices. Authors’ strong believe is that although EPR tool embraces viable and progressive concepts is highly liberalized in its ap
Read More